Kalera Reports Financial Results for Fourth Quarter 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
| Callisto Pharmaceuticals, Inc. (NASDAQ: KAL) | Delayed: 1.12 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.12 | 52 Week High | $0.27 | |||
| Open | $19.49 | 52 Week Low | $0.16 | |||
| Day High | $1.12 | P/E | N/A | |||
| Day Low | $1.12 | EPS | $-0.50 | |||
| Volume | 678 | |||||
| (AMEX: KSLLF) | Delayed: 0.52 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.52 | 52 Week High | $ | |||
| Open | $32.31 | 52 Week Low | $ | |||
| Day High | $0.52 | P/E | N/A | |||
| Day Low | $0.52 | EPS | $ | |||
| Volume | 99,381 | |||||
